598 Airport Boulevard
At kSep Systems, we leverage our innovation, engineering, and cGMP manufacturing expertise to produce robust and automated single-use bioprocessing solutions for our clients in the areas of recombinant therapeutics, cell therapy, and vaccines manufacturing. kSep's underlying technology was originally developed and applied by Dr. Heath Herman of KBI Biopharma, who suffered with Muscular Dystrophy and passed away in 2006. The original technology was redesigned and transformed into fully automated single-use centrifugation solution as the kSep technology. Since KBI Biopharma's mission is to provide biopharmaceutical contract development and manufacturing services, kSep Systems, LLC, was setup in 2011 as a spinoff to commercialize the kSep technology.
CEO: Sunil Mehta, PhD